|
Media Mentions
|
1/15/14
A Sweet LifeBlog post highlights Tedx talk by Doug Melton, PhD, on his work to cure diabetes. 1/12/14 MedPageTodayAlbert Lam, MD, is quoted on kidney regeneration studies.
|
|
Recent HSCI Papers
|
1/12/14 Nature - Shivdasani Lab Broadly permissive intestinal chromatin underlies lateral inhibition and cell plasticity 1/9/14 Blood - Langenau Lab Pten regulates zebrafish hematopoiesis 1/2/14 Cell Stem Cell - Mullen Lab Hippo tips the TGF- β scale in favor of pluripotency |
|
Controlling Cells After Transplant
Jeff Karp, PhD, uses particle engineering to improve cell therapy.
Karp and James Ankrum, PhD, demonstrate in Nature Protocols how to load cells with microparticles that provide the cells cues for how they should behave over the course of days or weeks as the particles degrade.
They hope the paper will encourage others in the scientific community to apply the technique to their fields. The paper shows the range of different cell types that can be particle engineered, including stem cells, immune cells, and pancreatic cells. Read the whole story.
|
Kidney Program Milestone
Joseph Bonventre, MD, PhD, and Albert Lam, MD, generate kidney tubular cells from stem cells.
|
|
|
More Research News
- Alexander Schier, PhD, found an early developmental signal, dubbed "Toddler," hidden in "non-coding" RNA.
- David Scadden, MD, published a new map of cell behavior revealing key proteins that cells destroy, one of which is NCoR1.
- Dan Tenen, PhD, identified new candidates for the treatment of an acute myeloid leukemia subtype caused by mutations of CEBPA, a tumor suppressor.
|
|
Member News
- Amy Wagers, PhD, and Rich Lee, MD, are named honorable mentions for 2013 Bostonians of the Year.
- Sandra McAllister, PhD, was named the recipient of a Presidential Early Career Award for Scientists and Engineers.
- Khalid Shah, PhD, published his latest book, Mesenchymal Stem Cells in Cancer Therapy, an Elsevier publication.
- Bio-inspired glue from the lab of Jeff Karp, PhD, will be a featured product of start-up company Gecko Biomedical.
|
|
|
|
|
|
|
|
Harvard stem cell researchers have successfully coaxed stem cells to become kidney tubular cells, a significant advance toward one day using regenerative medicine, rather than dialysis and transplantation, to treat kidney failure. The findings are published in the